- Home
- QH vs PASG Comparison
QH vs PASG Comparison
Compare QH & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QH | PASG |
|---|---|---|
| Founded | 2012 | 2017 |
| Country | China | United States |
| Employees | N/A | 27 |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8M | 14.8M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | QH | PASG |
|---|---|---|
| Price | $4.62 | $4.70 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | ★ 26.1K | 17.4K |
| Earning Date | 04-02-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.86 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.06 | $3.29 |
| 52 Week High | $12.81 | $20.00 |
Technical Indicators
Market Signals| Indicator | QH | PASG |
|---|---|---|
| Relative Strength Index (RSI) | 45.63 | 51.02 |
| Support Level | $3.90 | $4.25 |
| Resistance Level | $5.40 | $4.94 |
| Average True Range (ATR) | 0.49 | 0.26 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 40.67 | 83.81 |
Price Performance
Historical ComparisonAbout QH Quhuo Limited American Depository Shares
Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services. It generates maximum of its revenue from the on-demand delivery solutions segment.
About PASG Passage Bio Inc.
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.